AUSTIN DUERKSEN: Open Payments
NPI 1396267803 · OMAHA, NE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$9,702 in 62 payments from 21 companies in 2025. Trend: 2023 $212 · 2024 $2,097 · 2025 $9,702
Long term medical supply or device loan: $7,136Food & beverage: $1,602Travel & lodging: $964
| Company | Payments | Amount |
|---|---|---|
| INTERNATIONAL REHABILITATIVE SCIENCES, INC | 2 | $7,217 |
| Boston Scientific Corporation | 8 | $1,436 |
| ABBVIE INC. | 16 | $302 |
| Lundbeck LLC | 3 | $79 |
| PROTEGA PHARMACEUTIALS INC | 4 | $78 |
| Collegium Pharmaceutical, Inc. | 4 | $73 |
| TerSera Therapeutics LLC | 2 | $68 |
| VERTEX PHARMACEUTICALS INCORPORATED | 3 | $64 |
| PFIZER INC. | 3 | $55 |
| MML US, Inc. | 3 | $46 |
Products named: RS-4i Plus with Intersperse, General - Therapies, WaveWriter Alpha Prime 16, BOTOX, QULIPTA, VYEPTI, ROXYBOND, Prialt.
Industry payments across NE — which companies pay providers there.
